Navigation Links
Insulet Reports Third Quarter 2008 Results
Date:11/6/2008

rn rates, the Company concluded that it had sufficient historical data on which to base its estimated returns beginning January 1, 2008. The following summary table is provided to improve investors' understanding of growth in patient volume and product shipments.

Revenue

Adjustment for

change in

deferred

revenue

GAAP estimate Non-GAAP

(In thousands, unaudited)

Three months ended June 30, 2008 $7,417 131 $7,548

Three months ended September 30, 2008 $10,110 (137) $9,973

Nine months ended September 30, 2008 $24,198 (1,217) $22,981

Revenue reported for the three and nine months ended September 30, 2007, was not affected by the change in estimate of deferred revenue.

Forward-Looking Statement

The third quarter 2008 financial results contained in this news release are subject to finalization in connection with the preparation of the Company's Quarterly Report on Form 10-Q report for the three and nine months ended September 30, 2008. This press release contains forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future, including those related to its revenues, patient base, manufacturing capacity, expenses, product costs, sales and marketing efforts, product demand and financial performance. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on it. There can be no assurance that future developments affecting it will be those that it h
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... incretin mimetic claims continue to move forward in U.S. ... issued by AstraZeneca PLC on July 31, 2014, Byetta ... named in 409 product liability claims that allege the ... documents indicate that many of these claims are pending ...
(Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
(Date:8/30/2014)... 30, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
(Date:8/30/2014)... PA (PRWEB) August 30, 2014 "My ... result of a car accident," said one of two ... muscle strain in her shoulder and neck area. She ... invented reduced pain and pressure, assisting in comfort and ... the patent-pending PILLOW CRADLE to support the head, neck ...
(Date:8/30/2014)... Market Research Report on Global and ... and in-depth market survey on Global and Chinese ... basic information of Lab Oven including its classification, ... global and China’s top manufacturers of Lab Oven ... market share etc. , The report further analyzes ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Expanding Care at the Forefront of Dermatology 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... QMed, Inc., (Nasdaq:,QMED) today announced that its subsidiary, QMedCare ... Special Needs Plan in New Jersey. The,Company is working ... and the Centers for Medicare and Medicaid Services (CMS) ... the New Jersey Special Needs,Plan., The Company is ...
... Avalon CEO brings leadership and entrepreneurial expertise to ... ... Dreamerz Foods, Inc., the,creator of Dreamerz, the first ever all-natural sleep ... Products, as the newest member of the San Francisco-based company,s,Board of ...
... Dec. 27 Cogdell Spencer Inc.,(NYSE: CSA ) ... St.,Luke,s Hospital and Health Network of Bethlehem, Pennsylvania to ... 383,000 square,foot project will consist of a cancer center, ... The two medical office buildings are valued between $35 ...
... EL SEGUNDO, Calif., Dec. 27 Computer ... that it has signed an extension to,a ... with Sun Microsystems Inc., Under the ... all,applications development and support services for Sun,s ...
... Sciences (NIEHS), part of the National Institutes of ... for the first year of funding to three ... Through Specialized Clinically-Oriented Ventures in Environmental Research. The ... gap between basic research and clinical treatment of ...
... to Commercial Operations, SEATTLE, Dec. 27 ... that it has completed its,acquisition of Zevalin(R) (ibritumomab ... marketing, sales, and development of the drug,in the ... outside the United,States by Bayer Schering under an ...
Cached Medicine News:Health News:Gilbert Pritchard, Jr. Joins Board of Directors at Dreamerz Foods, Inc. 2Health News:Gilbert Pritchard, Jr. Joins Board of Directors at Dreamerz Foods, Inc. 3Health News:Cogdell Spencer Announces a $100 Million Development at St. Luke's Riverside Outpatient Campus In Bethlehem, Pennsylvania 2Health News:CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems 2Health News:NIEHS awards DISCOVER grants 2Health News:NIEHS awards DISCOVER grants 3Health News:Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States 2Health News:Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States 3Health News:Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States 4Health News:Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States 5
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... methods developed to prevent and eradicate the prevalence of ... methods are confined to low specificity, safety and large ... look for a better solution. It has been discovered ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... Richard-Allan Scientific Resolve Immersion Oil ... allows light transmission throughout most of ... in both low and high viscosity, ... a refractive index of 1.5150. Resolve ...
Immersion Oil, 1,250 cs...
... Type DF is the highest resolution ... microscopy and it also exhibits extremely ... FF has virtually zero fluorescence and ... oil of choice when low levels ...
... and monitors the movement of blood products ... Courier provides a complete audit trail of ... BloodTrack Courier electronically records a blood units ... receipt of blood products through to the ...
Medicine Products: